201 related articles for article (PubMed ID: 36543682)
1. Factors associated with humoral immune response in older adults who received egg-free influenza vaccine.
Williams KV; Moehling Geffel K; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Susick M; Zimmerman RK
Vaccine; 2023 Jan; 41(3):862-869. PubMed ID: 36543682
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of antibody response to 2019-20 cell-based inactivated and egg-based live attenuated influenza vaccines in children and young adults.
Williams KV; Zhai B; Alcorn JF; Patricia Nowalk M; Levine MZ; Kim SS; Flannery B; Moehling Geffel K; Jaber Merranko A; Nagg JP; Collins M; Susick M; Clarke KS; Zimmerman RK; Martin JM
Vaccine; 2022 Jan; 40(5):780-788. PubMed ID: 34952751
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the Immunogenicity of Cell Culture-Based and Recombinant Quadrivalent Influenza Vaccines to Conventional Egg-Based Quadrivalent Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized Open-Label Trial.
Dawood FS; Naleway AL; Flannery B; Levine MZ; Murthy K; Sambhara S; Gangappa S; Edwards L; Ball S; Grant L; Belongia E; Bounds K; Cao W; Gross FL; Groom H; Fry AM; Rentz Hunt D; Jeddy Z; Mishina M; Kim SS; Wesley MG; Spencer S; Thompson MG; Gaglani M
Clin Infect Dis; 2021 Dec; 73(11):1973-1981. PubMed ID: 34245243
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of antibody response to 2018-19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children.
Moehling KK; Zimmerman RK; Nowalk MP; Jeng Lin C; Martin JM; Alcorn JF; Susick M; Burroughs A; Holiday C; Flannery B; Levine MZ
Vaccine; 2020 Jul; 38(33):5171-5177. PubMed ID: 32580919
[TBL] [Abstract][Full Text] [Related]
5. Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
Liu Z; Pang C; Deng Y; Guo C; Li J; Li Y; Xin R; Li X; Xu C; Huang C; Lu H; Li J
Vaccine; 2023 Jul; 41(34):4978-4985. PubMed ID: 37394372
[TBL] [Abstract][Full Text] [Related]
6. Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines.
Liu F; Gross FL; Joshi S; Gaglani M; Naleway AL; Murthy K; Groom HC; Wesley MG; Edwards LJ; Grant L; Kim SS; Sambhara S; Gangappa S; Tumpey T; Thompson MG; Fry AM; Flannery B; Dawood FS; Levine MZ
Nat Commun; 2024 Jan; 15(1):254. PubMed ID: 38177116
[TBL] [Abstract][Full Text] [Related]
7. Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season.
Ganczak M; Dubiel P; Drozd-Dąbrowska M; Hallmann-Szelińska E; Szymański K; Brydak LB
Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31739554
[TBL] [Abstract][Full Text] [Related]
8. Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
Gaglani M; Kim SS; Naleway AL; Levine MZ; Edwards L; Murthy K; Dunnigan K; Zunie T; Groom H; Ball S; Jeddy Z; Hunt D; Wesley MG; Sambhara S; Gangappa S; Grant L; Cao W; Gross FL; Mishina M; Fry AM; Thompson MG; Dawood FS; Flannery B
Clin Infect Dis; 2023 Feb; 76(3):e1168-e1176. PubMed ID: 36031405
[TBL] [Abstract][Full Text] [Related]
9. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
10. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
Front Immunol; 2018; 9():2465. PubMed ID: 30405641
[No Abstract] [Full Text] [Related]
11. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
Loebermann M; Voss U; Meyer S; Bosse D; Fritzsche C; Klammt S; Frimmel S; Riebold D; Reisinger EC
PLoS One; 2013; 8(8):e70866. PubMed ID: 23976960
[TBL] [Abstract][Full Text] [Related]
12. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
Sundaram ME; Meydani SN; Vandermause M; Shay DK; Coleman LA
Nutr Res; 2014 Feb; 34(2):149-54. PubMed ID: 24461316
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.
Niang M; Deming ME; Goudiaby D; Diop OM; Dia N; Diallo A; Ortiz JR; Diop D; Lewis KDC; Lafond KE; Widdowson MA; Victor JC; Neuzil KM
Vaccine; 2020 Nov; 38(47):7526-7532. PubMed ID: 33012603
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to intradermal and intramuscular inactivated influenza vaccine among older age group.
Boonnak K; Dhitavat J; Thantamnu N; Kosoltanapiwat N; Auayporn M; Jiang L; Puthavathana P; Pitisuttithum P
Vaccine; 2017 Dec; 35(52):7339-7346. PubMed ID: 29157960
[TBL] [Abstract][Full Text] [Related]
16. Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.
Cowling BJ; Perera RAPM; Valkenburg SA; Leung NHL; Iuliano AD; Tam YH; Wong JHF; Fang VJ; Li APY; So HC; Ip DKM; Azziz-Baumgartner E; Fry AM; Levine MZ; Gangappa S; Sambhara S; Barr IG; Skowronski DM; Peiris JSM; Thompson MG
Clin Infect Dis; 2020 Oct; 71(7):1704-1714. PubMed ID: 31828291
[TBL] [Abstract][Full Text] [Related]
17. Interseason waning of vaccine-induced hemagglutination inhibition antibody titers and contributing factors to pre-existing humoral immunity against influenza in community-dwelling older adults 75 years and older.
Wunderlich B; Laskow T; Li H; Zhang L; Abrams E; Tian J; Yu J; Chen Y; Tavenier J; Huang Y; Talaat K; Bream JH; Xue QL; Pawelec G; Leng SX
Immun Ageing; 2023 Jul; 20(1):38. PubMed ID: 37525151
[TBL] [Abstract][Full Text] [Related]
18. Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
Shinde V; Cai R; Plested J; Cho I; Fiske J; Pham X; Zhu M; Cloney-Clark S; Wang N; Zhou H; Zhou B; Patel N; Massare MJ; Fix A; Spindler M; Thomas DN; Smith G; Fries L; Glenn GM
Clin Infect Dis; 2021 Dec; 73(11):e4278-e4287. PubMed ID: 33146720
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in Children.
Williams KV; Li ZN; Zhai B; Alcorn JF; Nowalk MP; Levine MZ; Kim SS; Flannery B; Moehling Geffel K; Merranko AJ; Collins M; Susick M; Clarke KS; Zimmerman RK; Martin JM
J Pediatric Infect Dis Soc; 2023 Jun; 12(6):342-352. PubMed ID: 37232430
[TBL] [Abstract][Full Text] [Related]
20. Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
Belongia EA; Levine MZ; Olaiya O; Gross FL; King JP; Flannery B; McLean HQ
Vaccine; 2020 Mar; 38(15):3121-3128. PubMed ID: 32145994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
